{"id":"https://openalex.org/W2687901290","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e19511","title":"Meta-analysis of the effects on safety of front-loading (FL), every-2-week (Q2W), and Q3W dosing of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA).","display_name":"Meta-analysis of the effects on safety of front-loading (FL), every-2-week (Q2W), and Q3W dosing of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA).","publication_year":2012,"publication_date":"2012-05-20","ids":{"openalex":"https://openalex.org/W2687901290","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e19511","mag":"2687901290"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2012.30.15_suppl.e19511","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e19511","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e19511","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":["David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052972588","display_name":"Dusan Kotasek","orcid":"https://orcid.org/0000-0002-2170-3560","observed_orcids":["https://orcid.org/0000-0002-2170-3560"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dusan Kotasek","raw_affiliation_strings":["Adelaide Cancer Centre, Kurralta Park, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adelaide Cancer Centre, Kurralta Park, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110044973","display_name":"Jean-Luc Re Canon","orcid":"https://orcid.org/0009-0000-3016-9323","observed_orcids":["https://orcid.org/0009-0000-3016-9323"]},"institutions":[{"id":"https://openalex.org/I4210152698","display_name":"Grand Charleroi Hospital","ror":"https://ror.org/05ma41w62","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210152698"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean-Luc Canon","raw_affiliation_strings":["Grand H\u00f4pital de Charleroi (GHdC), Charleroi, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grand H\u00f4pital de Charleroi (GHdC), Charleroi, Belgium","institution_ids":["https://openalex.org/I4210152698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108398637","display_name":"Dianne K. Tomita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dianne Tomita","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030963552","display_name":"Helen Collins","orcid":"https://orcid.org/0000-0001-5188-1790","observed_orcids":["https://orcid.org/0000-0001-5188-1790"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helen Collins","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072563567","display_name":"Lee Steven Schwartzberg","orcid":"https://orcid.org/0000-0002-7433-3428","observed_orcids":["https://orcid.org/0000-0002-7433-3428"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lee Steven Schwartzberg","raw_affiliation_strings":["The West Clinic, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The West Clinic, Memphis, TN","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0514,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.06467662,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"30","issue":"15_suppl","first_page":"e19511","last_page":"e19511"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darbepoetin-alfa","display_name":"darbepoetin alfa","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.8889999985694885},{"id":"https://openalex.org/keywords/dosing-frequency","display_name":"dosing frequency","score":0.6370000243186951},{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.9900000095367432},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5630000233650208},{"id":"https://openalex.org/keywords/thromboembolic-events","display_name":"thromboembolic events","score":0.9229999780654907},{"id":"https://openalex.org/keywords/hemoglobin-response","display_name":"hemoglobin response","score":0.7229999899864197},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5239999890327454},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8131728172302246},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7672562003135681},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.5714837908744812},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.44231465458869934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41263347864151},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.38294270634651184},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3516569435596466}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2012.30.15_suppl.e19511","doi":"https://doi.org/10.1200/jco.2012.30.15_suppl.e19511","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2012.30.15_suppl.e19511","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2335947880","https://openalex.org/W2245074238","https://openalex.org/W7055484069","https://openalex.org/W7046223718","https://openalex.org/W7064645447","https://openalex.org/W2286319063","https://openalex.org/W2284900210","https://openalex.org/W2140818951","https://openalex.org/W2278151493","https://openalex.org/W4254412577"],"abstract_inverted_index":{"e19511":[0],"Background:":[1],"Several":[2],"studies":[3,28,68,107],"evaluated":[4],"if":[5],"alternate":[6],"dosing":[7,47,57,103,244],"could":[8],"decrease":[9],"the":[10,32,84,100,106],"time":[11],"to":[12,31,177,239],"hemoglobin":[13],"(Hb)":[14],"response.":[15],"With":[16],"recent":[17],"safety":[18,35,59],"concerns,":[19],"this":[20,229],"is":[21],"now":[22],"of":[23,34,42,48,206,211,228,245],"limited":[24],"interest;":[25],"however,":[26],"these":[27,233],"may":[29],"contribute":[30],"understanding":[33],"risks.":[36],"This":[37],"study-level":[38],"meta-analysis":[39,230],"examined":[40],"effects":[41,165],"FL,":[43,70,172,217,240],"Q2W,":[44,72,173,218,241],"and":[45,54,80,108,152,155,201,219],"Q3W":[46,136,175,220,243],"DA":[49,56,96,112,133],"vs":[50],"epoetin":[51],"alfa":[52],"(EA)":[53],"weekly":[55],"on":[58,145],"in":[60,82,99,194,216],"pts":[61],"with":[62,223],"CIA.":[63],"Methods:":[64],"Data":[65],"from":[66],"11":[67],"(4":[69],"5":[71,122],"1":[73,75],"Q3W,":[74],"Q2W/Q3W)":[76],"conducted":[77],"between":[78,105],"1999":[79],"2006":[81],"which":[83],"comparison":[85],"group":[86],"received":[87],"3-times-per-week":[88],"(TIW)":[89],"or":[90,94,115,121,124,137,174,180,204,242],"once-weekly":[91],"(QW)":[92],"EA":[93],"QW":[95,118,140,181],"were":[97,214,236],"included":[98,143],"meta-analysis.":[101],"FL":[102],"differed":[104],"was":[109,186],"defined":[110],"as":[111],"4.5":[113,134],"mcg/kg":[114,135],"300":[116],"mg":[117],"for":[119,196],"4":[120],"weeks":[123],"until":[125],"Hb":[126,157,212],">":[127],"12":[128],"g/dL":[129,160],"followed":[130],"by":[131],"either":[132,178],"a":[138,207],"lower":[139],"dose.":[141],"Endpoints":[142],"deaths":[144],"study;":[146],"disease":[147],"progression":[148],"(PD);":[149],"embolic,":[150,199],"thrombotic,":[151,200],"thromboembolic":[153,202],"events;":[154],"rapid":[156,209],"rise":[158,213],"(1":[159],"within":[161],"14":[162],"days).":[163],"Random":[164],"odds":[166],"ratios":[167],"(ORs)":[168],"are":[169],"provided":[170],"comparing":[171],"arms":[176,221],"TIW":[179],"active":[182],"control":[183],"arms.":[184],"Heterogeneity":[185],"assessed":[187],"using":[188],"I2":[189],"statistic.":[190],"Results:":[191],"No":[192],"differences":[193],"ORs":[195],"death,":[197],"PD,":[198],"events":[203,235],"evidence":[205],"more":[208],"rate":[210],"observed":[215],"compared":[222],"controls":[224],"(table).":[225],"Conclusions:":[226],"Results":[227],"suggested":[231],"that":[232],"adverse":[234],"not":[237],"related":[238],"DA.":[246],"[Table:":[247],"see":[248],"text]":[249]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-06-30T00:00:00"}